We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
+12.97%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.56%
5 Year Est. Return
+159.19%
10 Year Est. Return
+649.1%
AUM
$49B
AUM Growth
+$4.18B
Cap. Flow
-$2.19B
Cap. Flow %
-4.47%
Top 10 Hldgs %
27.26%
Holding
2,634
New
385
Increased
693
Reduced
766
Closed
516

Sector Composition

Rank Sector Weight
1 Technology 1.5%
2 Financials 0.8%
3 Consumer Discretionary 0.56%
4 Communication Services 0.45%
5 Industrials 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
1051
CALL
Sanofi
SNY
$104B
$2.49M 0.01%
+50,000
New +$2.44M
CB icon
1052
CALL
Chubb
CB
$135B
$2.49M 0.01%
+11,000
New +$2.41M
GLPI icon
1053
CALL
Gaming and Leisure Properties
GLPI
$12.8B
$2.47M 0.01%
50,000
SKX
1054
DELISTED
Skechers
SKX
$2.44M 0.01%
39,193
+16,195
+70% +$873K
TWO
1055
PUT
Two Harbors Investment
TWO
$1.27B
$2.43M 0.01%
174,400
ZION icon
1056
Zions Bancorporation
ZION
$10.3B
$2.41M ﹤0.01%
55,009
+54,743
+20,580% +$1.98M
BILI icon
1057
Bilibili
BILI
$7.84B
$2.41M ﹤0.01%
198,198
+74,263
+60% +$969K
LEGN icon
1058
CALL
Legend Biotech
LEGN
$4.01B
$2.41M ﹤0.01%
+40,000
New +$2.53M
PBR icon
1059
PUT
Petrobras
PBR
$116B
$2.4M ﹤0.01%
150,000
BNTX icon
1060
CALL
BioNTech
BNTX
$23.5B
$2.39M ﹤0.01%
22,600
+7,000
+45% +$705K
VALE icon
1061
PUT
Vale
VALE
$62.6B
$2.38M ﹤0.01%
150,000
GSK icon
1062
GSK
GSK
$106B
$2.38M ﹤0.01%
64,180
-5,875
-8% -$211K
APLS
1063
DELISTED
Apellis Pharmaceuticals
APLS
$2.36M ﹤0.01%
+39,392
New +$2M
WAL icon
1064
Western Alliance Bancorporation
WAL
$8.87B
$2.35M ﹤0.01%
+35,772
New +$1.8M
CALY
1065
CALL
Callaway Golf Company
CALY
$3.14B
$2.34M ﹤0.01%
+163,400
New +$2.1M
KMX icon
1066
CALL
CarMax
KMX
$8.26B
$2.34M ﹤0.01%
30,500
-3,000
-9% -$202K
ETRN
1067
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$2.32M ﹤0.01%
+227,500
New +$2.14M
BHC icon
1068
PUT
Bausch Health
BHC
$2.34B
$2.31M ﹤0.01%
288,300
Z icon
1069
PUT
Zillow
Z
$7.56B
$2.3M ﹤0.01%
39,800
-64,300
-62% -$2.83M
ZBRA icon
1070
PUT
Zebra Technologies
ZBRA
$17.8B
$2.3M ﹤0.01%
8,400
-1,200
-13% -$274K
EGHT icon
1071
PUT
8x8 Inc
EGHT
$332M
$2.29M ﹤0.01%
605,000
SAGE
1072
CALL
DELISTED
Sage Therapeutics
SAGE
$2.28M ﹤0.01%
105,400
+91,900
+681% +$1.82M
MPT
1073
CALL
Medical Properties Trust
MPT
$2.81B
$2.28M ﹤0.01%
463,500
-3,000
-0.6% -$14.7K
CME icon
1074
PUT
CME Group
CME
$94.8B
$2.27M ﹤0.01%
10,800
PR
1075
CALL
Permian Resources
PR
$16.9B
$2.27M ﹤0.01%
+167,100
New +$2.29M

Similar funds

Parallax Volatility Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Parallax Volatility Advisers held 2,634 positions worth $49B, up 9.3% from $44.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Parallax Volatility Advisers withdrew a net $2.19B in Q4 2023, closing 516 positions and reducing 766 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 1.1% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Parallax Volatility Advisers opened a new position in Invesco QQQ Trust worth $252M.

  • Parallax Volatility Advisers's largest Q4 2023 buy was Invesco QQQ Trust: 615,330 shares worth $252M.
  • Parallax Volatility Advisers added most to NVIDIA in Q4 2023, an estimated $246M increase.
  • Parallax Volatility Advisers's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $84M.
  • Parallax Volatility Advisers fully exited iShares Russell 2000 ETF in Q4 2023, selling an estimated $160M.
  • Parallax Volatility Advisers's ten largest holdings make up 27% of its $49B portfolio in Q4 2023.
  • Parallax Volatility Advisers opened 385 new positions and closed 516 in Q4 2023.
  • Parallax Volatility Advisers's portfolio value rose 9.3% quarter-over-quarter to $49B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.